This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Amyris Names Charles Kraft As Vice President Of Global Manufacturing & Process Development

EMERYVILLE, Calif., Oct. 9, 2012 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leading renewable chemicals and fuels company, today announced that Charles Kraft, a specialty fermentation industry veteran, has been appointed Vice President of Global Manufacturing and Process Development.

" Chuck's experience and leadership will complement Amyris's manufacturing and process development team. We've successfully engineered yeast strains to make farnesene, artemisinic acid, and a fragrance ingredient. With our first purpose-built farnesene plant in the final stages of commissioning in Brazil, Chuck will help take our industrial manufacturing capability to its next phase — continuous operational improvements and process optimization as we continue on track to scale up our production and to drive down our production cost," said John Melo, President and Chief Executive Officer of Amyris.

Prior to joining Amyris, Kraft was Vice President of Operations, and earlier Vice President of Engineering, at DuPont Tate and Lyle BioProducts, a joint venture producing 1, 3-propanediol (Bio-PDO™) via fermentation of plant-based sugars. Previously, for nearly two decades, he held a number of operational positions at Tate & Lyle's citric acid production facility in the United States.

" Amyris is making history with its technology platform and the impending start-up of its facility at Para í so. Based on my review of Amyris's operations in California, Illinois, and Brazil over the last several weeks, Amyris is well on track to become a predictable, reliable manufacturer of renewable chemicals and fuels to meet growing customer demand. I am excited to leverage my experience in industrial fermentation with the manufacturing base and talented team that is already in place," said Kraft.

About Amyris, Inc.

Amyris is an integrated renewable products company focused on providing sustainable alternatives to a broad range of petroleum-sourced products. Amyris uses its industrial synthetic biology platform to convert plant sugars into a variety of hydrocarbon molecules—flexible building blocks that can be used in a wide range of products. Amyris's initial portfolio of commercial products is based on Biofene®, Amyris's brand of renewable farnesene, a long-chain hydrocarbon. Amyris is commercializing these products both as No Compromise® renewable ingredients in cosmetics, flavors and fragrances, polymers, lubricants and consumer products, and also as No Compromise renewable diesel and jet fuel. Amyris Brasil Ltda., a subsidiary of Amyris, oversees the establishment and expansion of Amyris's production in Brazil. More information about Amyris is available at .

The Amyris, Inc. logo is available at

Forward-Looking Statements

This release contains forward-looking statements, and any statements other than statements of historical facts could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events (such as the anticipated commissioning and start-up of Amyris's manufacturing facility at Para í so Bioenergia, expansion and reliability of Amyris manufacturing, Amyris's leadership with respect to industrial synthetic biology, and customer demand for Amyris renewable products) that involve risks and uncertainties. These statements are based on management's current expectations and actual results and future events may differ materially due to risks and uncertainties, including those associated with any delays or failures in development, production or commercialization of products, liquidity and ability to fund capital expenditures, Amyris's reliance on third parties to achieve its goals, and other risks detailed in the "Risk Factors" section of Amyris's quarterly report on Form 10-Q filed on August 8, 2012. Amyris disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

Amyris, Biofene and No Compromise are trademarks or registered trademarks of Amyris, Inc. This press release also contains trademarks of other businesses that are the property of their respective owners.
CONTACT: Media Contacts
         Joel Velasco
         +1 (510) 597-5577

company logo

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs